Rezultati pretraživanja
  1. prije 13 sati
    Odgovor korisnicima i sljedećem broju korisnika:

    that's brilliant news, and more than deserved for all your work in HIV and activism!!

  2. « All medicines are poisonous. It is only under the most controlled conditions that they do good » said

  3. prije 15 sati
  4. 4. velj

    High medicines' prices have become a global problem: "Norway, a rich country, had to deny the entry to the market of 21 medicines in 2019 because of their high prices", noted the representative of Norway

  5. 4. velj

    Very true! And with the opening up for global collaboration, should become its number 1 collaborating partner in all things

  6. 4. velj
  7. 4. velj

    Calls from for new government to give faster access to life-saving drugs, as patients in Ireland wait three times longer for new medicines, inc cancer drugs, as patients in other comparable European countries

    Prikaži ovu nit
  8. 4. velj
  9. 4. velj

    は 、を通じて 治療薬の一つ、DEC錠を必要とする全ての蔓延国でLF制圧が達成されるまで無償で提供します。 2020年1月末現在、28カ国に約19.7億錠を提供しました。

  10. play a key role in making medicines more affordable says . We owe it to to listen to those who are in charge of paying for .

  11. 3. velj
  12. 2. velj
  13. 31. sij

    On Feb 3-8, 146th EB will take place in Geneva. 34 Board Members will deliberate on main issues at stake, incl on . See recent publications 📷: WHO

  14. 31. sij
  15. 31. sij
  16. 30. sij

    Dear . Don't let the hubbub be an excuse to keep neglecting neglected diseases, or to treat them, on . It's past time for reforms to ensure Canadians have access to WHO . 🇨🇦💊

  17. 30. sij

    “No lottery for life” say countries to companies Novartis and Avexis today. Meaningful innovation should not be expensive, unaffordable nor unsustainable. 🔎 🔎

  18. 30. sij

    No “lottery for life” - latest statement by Health Ministers against & ...Health Ministers sound more & more like activists some may say - in . Here is why:

  19. 30. sij

    No “lottery for life” - Statement by Beneluxa Health Ministers addressing the global managed access program designed by Novartis and Avexis

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.